Phenotypic and differentiation stability of human embryonic stem cell-derived osteoblasts

Area of Science:

• Stem cell biology
• Regenerative medicine
• Bone tissue engineering

Background:

• Human embryonic stem cell-derived osteoblast-like cells (hESC-OS) show promise for bone regeneration.
• Ensuring the safety and efficacy of transplanted cells requires understanding the impact of long-term expansion.

Purpose of the Study:

• To evaluate the effects of continuous cell expansion on hESC-OS differentiation stability.
• To assess pluripotency and tumorigenic potential of long-term expanded hESC-OS.
• To determine the suitability of expanded hESC-OS for bone regeneration applications.

Main Methods:

• hESC-OS were serially passaged up to passage 25.
• Gene expression analysis of osteogenic, pluripotency, and tumorigenesis markers was performed.
• In vivo teratoma formation assays in nude mice were conducted.
• Recultivation in hESC conditions assessed potential dedifferentiation.

Main Results:

• Comparable osteoblast differentiation was observed between aggregate and single-cell derived hESC-OS.
• Osteoblast gene expression peaked at passages 5-10, then declined.
• No significant increase in tumor-associated gene expression was detected.
• Only early passage hESC-OS formed teratomas in vivo; dedifferentiation did not occur.

Conclusions:

• Expanded hESC-OS exhibit stable lineage-specific differentiation.
• Long-term expanded hESC-OS do not retain pluripotency and are genetically stable.
• hESC-OS are suitable for further investigation in large animal preclinical studies for bone regeneration.